Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Sales | 1,262 | 1,386 | 1,277 | 1,912 | 652 |
| Cost of Goods | 749 | 782 | 776 | 1,087 | 471 |
| Gross Profit | 513 | 604 | 501 | 825 | 181 |
| Operating Expenses | 10,357 | 7,805 | 1,706 | 6,516 | 6,904 |
| Operating Income | -9,095 | -6,419 | -429 | -5,604 | -6,252 |
| Interest Expense | 307 | 346 | 374 | 400 | 360 |
| Other Income | -88 | -37 | -23 | -94 | 79 |
| Pre-tax Income | -9,490 | -6,802 | -826 | -6,098 | -6,533 |
| Net Income Continuous | -9,490 | -6,802 | -826 | -6,098 | -6,533 |
| Net Income | $-9,490 | $-6,802 | $-826 | $-6,098 | $-6,533 |
| EPS Basic Total Ops | -0.25 | -0.18 | -0.02 | -0.20 | -0.21 |
| EPS Basic Continuous Ops | -0.24 | -0.18 | -0.02 | -0.20 | -0.21 |
| EPS Diluted Total Ops | -0.25 | -0.18 | -0.02 | -0.20 | -0.21 |
| EPS Diluted Continuous Ops | -0.24 | -0.18 | -0.02 | -0.20 | -0.21 |
| EBITDA(a) | $-8,543 | $-5,843 | $288 | $-5,059 | $-5,705 |